Pep Coll
Impact in
- Virology top 10%
- HIV Research and Treatment
-
- HIV/AIDS Research and Interventions
- HIV/AIDS drug development and treatment
Papers in
-
- HIV/AIDS Research and Interventions 12
- HIV/AIDS drug development and treatment 2
- Epidemiology 12
- HIV, Drug Use, Sexual Risk 9
- Pneumocystis jirovecii pneumonia detection and treatment 2
- Co-authors
- James T Pacala (1 shared paper)Bonaventura Clotet (5 shared papers)Asunción Díaz (2 shared papers)Carlos Iniesta (2 shared papers)Michael Meulbroek (5 shared papers)Tomáš Hanke (2 shared papers)Lurdes Matas (1 shared paper)Christian Manzardo (2 shared papers)
- Journals
- PLoS ONE (3 papers)Journal of Virus Eradication (1 paper)Scientific Reports (1 paper)HIV Medicine (1 paper)The Journal of the American Board of Family Medicine (1 paper)
- Partner nations
- SpainIsraelUnited Kingdom
In The Last Decade
Pep Coll
15 papers receiving 134 citations
Peers
Comparison fields: 5 of 43
- Virology 39
- Infectious Diseases 78
- Microbiology 25
- Epidemiology 82
- Emergency Medicine 11
Countries citing papers authored by Pep Coll
This map shows the geographic impact of Pep Coll's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pep Coll with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pep Coll more than expected).
Fields of papers citing papers by Pep Coll
This network shows the impact of papers produced by Pep Coll. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pep Coll. The network helps show where Pep Coll may publish in the future.
Co-authors
The 25 scholars most cited alongside Pep Coll, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 26 | |
| 2 | 2018 | 22 | |
| 3 | 2020 | 20 | |
| 4 | 2021 | 16 | |
| 5 | Cytomegalovirus colitis in an older woman, successfully treated with ganciclovir. | 1992 | 13 |
| 6 | 2018 | 10 | |
| 7 | 2021 | 9 | |
| 8 | 2000 | 6 | |
| 9 | A placebo-controlled ati trial of HTI vaccines in early treated HIV infection | 2021 | 5 |
| 10 | 2022 | 4 | |
| 11 | 2023 | 3 | |
| 12 | 2020 | 1 | |
| 13 | 2023 | 1 | |
| 14 | 2019 | 1 | |
| 15 | 2015 | 1 | |
| 16 | El parlar del pallars | 1991 | 0 |
| 17 | 2025 | 0 | |
| 18 | 2022 | 0 | |
| 19 | El segle de la llum | 2014 | 0 |
About Pep Coll
Pep Coll is a scholar working on Infectious Diseases, Epidemiology, Virology, Emergency Medicine and Sociology and Political Science, having authored 19 papers that have together received 138 indexed citations. Recurring topics across this work include HIV/AIDS Research and Interventions (12 papers), HIV, Drug Use, Sexual Risk (9 papers), HIV Research and Treatment (7 papers), HIV-related health complications and treatments (3 papers), Pneumocystis jirovecii pneumonia detection and treatment (2 papers), Sex work and related issues (2 papers), HIV/AIDS drug development and treatment (2 papers) and Thyroid Disorders and Treatments (1 paper). The work is most often cited by research in Virology (39 citations), Infectious Diseases (78 citations), Microbiology (25 citations), Epidemiology (82 citations) and Emergency Medicine (11 citations). Pep Coll has collaborated with scholars based in Spain, Israel and United Kingdom. Frequent co-authors include James T Pacala, Bonaventura Clotet, Asunción Díaz, Carlos Iniesta, Michael Meulbroek, Tomáš Hanke, Lurdes Matas, Christian Manzardo, Gema Fernández and Elisa Martró. Their work appears in journals such as PLoS ONE, Journal of Virus Eradication, Scientific Reports, HIV Medicine and The Journal of the American Board of Family Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.